West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference
Rhea-AI Summary
West Pharmaceutical Services (NYSE: WST) announced its participation at CPHI Worldwide in Milan, Italy, showcasing its leadership in packaging and containment solutions for injectable drug administration. The company will present on Contamination Control Strategy in Primary Packaging as part of EU GMP Annex 1 revisions, highlighting the critical role of quality control in drug manufacturing.
West is also a finalist for a CPHI Award in the 'Heart of Pharma' category for its partnership with Fox Chase Cancer Center, recognizing philanthropic and community-based initiatives. The awards ceremony will take place on October 8, the opening night of CPHI.
Cindy Reiss-Clark, Chief Commercial Officer at West, emphasized the importance of third-party suppliers' quality control in maintaining a robust contamination control strategy for drug manufacturers.
Positive
- None.
Negative
- None.
News Market Reaction – WST
In the trading session that priced this news, WST declined 2.05%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
This year, West will highlight its industry expertise through a technical-focused presentation:
- Examining Contamination Control Strategy in Primary Packaging as part of EU GMP Annex 1- Wednesday, October 9 | 2:15 - 2:40 p.m.
- Presented by Ana Kuschel, Principal, Scientific Affairs, West
"The revisions to EU GMP Annex 1 represent a significant shift in drug manufacturing with over 30 references to primary packaging alone," said Cindy Reiss-Clark, Chief Commercial Officer at West. "At West, we know a drug manufacturer's contamination control strategy is only as strong as its weakest link, making the quality and control of materials from third party suppliers' critical factors to their process."
West is also a finalist for a CPHI Award in the "Heart of Pharma" category for its partnership with Fox Chase Cancer Center. This award recognizes companies, individuals and initiatives which nurture philanthropic, ethical and community-based ventures. Winners will be announced during the awards ceremony on the opening night of CPHI on October 8.
For more information about West, please visit our website: www.westpharma.com.
For more information about CPHI Worldwide, please visit: CPHI Milan
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-attend-and-showcase-industry-leadership-in-packaging-and-containment-at-cphi-worldwide-conference-302268066.html
SOURCE West Pharmaceutical Services, Inc.